Genmark diagnostics, inc. (GNMK)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Net loss

-47,350

-50,500

-61,850

-50,601

-42,197

-38,263

-33,643

-22,103

-23,970

-18,403

-19,963

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

7,268

7,088

5,317

3,916

3,405

2,656

2,530

1,198

1,326

1,063

1,569

Net amortization (accretion) of premiums/discounts on investments

133

142

39

-89

180

702

314

-

-

-

-

Gain on sale of investment in preferred stock

-

-

-

9

223

0

1,392

0

0

-

-

Net accretion of premiums/discounts on investments

1,740

938

1,132

388

285

0

0

0

0

-

-

Loss from disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-8

Impairment losses

-

-

-

-

-

-

-

-

-

-

1,506

Stock-based compensation

12,046

11,697

12,170

9,236

9,995

5,796

3,893

2,352

1,872

1,553

1,311

Provision for bad debt

338

23

14

13

25

0

2,721

-24

0

-

-

Non-cash inventory adjustments

2,631

1,426

1,323

134

-594

450

1,779

-482

517

-

-

Elimination of cumulative foreign currency translation adjustments upon liquidation of foreign subsidiary

-

-

-

-

-

-

-450

0

0

-

-

Impairment of intangible asset

-

-

-

-

-

-

1,624

0

0

-

-

Other non-cash adjustments

537

15

-224

145

186

185

0

0

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

5,584

878

1,555

2,250

1,983

2,030

2,390

2,068

420

508

51

Inventories

6,534

2,414

10,512

3,450

1,286

229

1,313

-880

1,742

651

-1,227

Prepaid expenses and other assets

750

-854

599

613

36

184

119

-68

-1,846

1,404

-316

Accounts payable

1,501

-1,389

2,557

4,105

-757

85

1,343

728

378

-1,058

-857

Accrued compensation

-885

1,059

-263

2,172

-458

1,797

951

1,811

979

547

-

Other current and non-current liabilities

249

-289

-893

1,088

355

-537

-544

1,397

0

-

-

Other current

-

-

-

-

-

-

-

-

-

-

-510

Net cash used in operating activities

-34,926

-32,512

-53,422

-35,637

-31,915

-29,572

-23,796

-16,243

-19,214

-18,861

-15,444

Investing activities:
Change in restricted cash

-

-

-

-

-

-

-585

1,343

0

-

-

Payments for intellectual property licenses

0

0

500

1,500

550

350

882

1,327

734

-

-

Purchases of property and equipment

2,092

2,575

4,815

7,000

3,756

5,726

4,270

3,476

1,376

1,860

1,069

Purchases of marketable securities

32,135

29,778

70,989

33,688

22,646

28,054

76,190

1,000

0

-

-

Proceeds from sales of marketable securities

0

0

13,896

8,015

223

-

-

-

-

-

-

Maturities of marketable securities

32,055

66,300

37,500

10,050

46,050

-

-

-

-

-

-

Proceeds from sales of marketable securities

-

-

-

-

-

7,497

6,643

0

0

-

-

Maturities of marketable securities

-

-

-

-

-

-56,050

-1,550

-5,000

5,000

-

-

Proceeds from the sale of property and equipment and intangible assets

-

-

-

-

-

-

-

-

-

-

10

Net cash used in investing activities

-2,172

33,947

-24,908

-24,123

19,321

29,417

-72,564

-2,146

-7,110

-1,860

-1,059

Financing activities:
Proceeds from issuance of common stock, net of offering costs

14,021

1,061

87,267

30,920

884

812

86,547

48,300

34,533

27,600

24,133

Costs incurred in conjunction with public offering

574

0

5,469

1,143

0

0

5,510

3,211

2,854

4,991

-

Principal repayment of borrowings

35,093

92

7,848

40

22

-

-

-

-

-

-

Proceeds from borrowings

70,000

7,098

15,000

10,000

10,000

-

-

-

-

-

-

Principal repayment of borrowings

-

-

-

-

-

56

766

1,984

417

-5

-

Payments associated with debt issuance

3,638

20

187

90

718

0

0

-

-

-

-

Proceeds from borrowings

-

-

-

-

-

0

166

991

2,000

-

-

Proceeds from stock option exercises

457

22

287

712

989

531

396

223

0

-

-

Net cash provided by financing activities

45,173

8,069

89,050

40,359

11,133

1,287

80,833

44,319

33,262

22,614

24,133

Effect of exchange rate changes on cash

-1

28

75

-25

-9

0

-

-

53

-47

30

Net increase in cash and cash equivalents

8,074

9,532

10,795

-19,426

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-1,470

1,132

-15,527

25,930

6,991

1,846

7,660

Non-cash investing and financing activities:
Transfer of systems to property and equipment from inventory

2,846

1,689

4,885

263

225

-

-

-

-

-

-

Property and equipment purchased with capital lease

-

-

-

-

-

-

-

109

0

-

-

Transfer of systems from property and equipment into inventory

-

-

-

-

-

256

575

223

46

109

-

Property and equipment costs incurred but not paid included in accounts payable

1,234

372

227

1,159

146

124

603

592

76

276

-

Reclassification of deposits on systems in other current assets and inventory to property and equipment

-

-

-

-

-

-

-

-

-

289

257

Offering costs incurred but not paid included in other liabilities

-

-

-

-

-

-

65

0

0

103

-

Supplemental cash flow information:
Cash received for income taxes, net

-

-

-

-

-

-

-

-

3

5

181

Cash paid for income taxes, net

-

-

-

-

-

24

21

91

0

-

-

Cash received for interest

-

-

-

-

-

244

403

42

21

25

33

Cash paid for interest

-

-

-

1,130

572

20

19

90

95

-

-

Cash paid for income taxes, net

155

165

61

65

10

-

-

-

-

-

-

Cash paid for interest

3,946

2,028

1,643

-

-

-

-

-

-

-

-

Leasehold improvements related to lease incentives

-

-

-

-

-

-

-

1,359

0

-

-

Intellectual property acquisitions included in other current liabilities

-

-

-

-

800

550

450

0

0

1,389

-